Sichuan Tongsheng Biopharmaceutical Co., Ltd.
Sichuan Tongsheng Biomedical Co., Ltd. (founded in 2011, Deyang) is committed to providing key starting materials (KSM) and intermediates for polypeptide drugs and chemical drugs. The products cover the screening, small trials, pilot trials to commercial production services of key materials for clinical new drugs, including polypeptide drugs KSM, Fmoc-amino acids, unnatural amino acids, polypeptide side chains, short peptides, and small molecular drugs KSM, Boc-amino acids, amino acid derivatives, and heterocyclic pharmaceutical intermediates. The company has a number of 50-5000L reactor multi-functional production lines (grams to 100 tons), R&D team of 30 people (including 2 doctorate, 6 master's), QC/QA of nearly 30 people; currently planning to build about 65 acres of new base (including GMP workshop, three multi-functional workshop and peptide protection amino acid line workshop), has provided custom synthesis services for the world's leading pharmaceutical companies, CDMO and API companies.